tadalafil has been researched along with Flushing in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gong, B; Huang, J; Huang, Y; Luo, Y; Ma, M; Sun, T; Xie, W; Yang, X | 1 |
Egawa, T; Ikeda, M; Kameyama, N; Kataoka, Y; Sejima, H; Shibuya, K; Shuto, H; Tominaga, K; Yamauchi, A | 1 |
Ahuja, S; Barada, J; Donatucci, C; Garcia, CS; Morgentaler, A; Natanegara, F; Niederberger, C; Wong, DG | 1 |
1 review(s) available for tadalafil and Flushing
Article | Year |
---|---|
Direct comparison of tadalafil with sildenafil for the treatment of erectile dysfunction: a systematic review and meta-analysis.
Topics: Back Pain; Controlled Clinical Trials as Topic; Erectile Dysfunction; Flushing; Humans; Male; Myalgia; Patient Preference; Phosphodiesterase 5 Inhibitors; Self Efficacy; Sildenafil Citrate; Tadalafil | 2017 |
1 trial(s) available for tadalafil and Flushing
Article | Year |
---|---|
Efficacy and safety of tadalafil across ethnic groups and various risk factors in men with erectile dysfunction: Use of a novel noninferiority study design.
Topics: Adult; Aged; Back Pain; Black or African American; Carbolines; Dose-Response Relationship, Drug; Dyspepsia; Erectile Dysfunction; Ethnicity; Flushing; Headache; Hispanic or Latino; Humans; Male; Middle Aged; Phosphodiesterase Inhibitors; Rhinitis; Surveys and Questionnaires; Tadalafil; Vasodilator Agents; White People | 2006 |
1 other study(ies) available for tadalafil and Flushing
Article | Year |
---|---|
Gender differences in tail-skin flushing induced by nitrates and phosphodiesterase type 5 inhibitors in a climacteric mouse model.
Topics: Animals; Carbolines; Climacteric; Cyclic Nucleotide Phosphodiesterases, Type 5; Female; Flushing; Gene Expression Regulation; Imidazoles; Male; Mice; Mice, Inbred ICR; Models, Animal; Nitrates; Phosphodiesterase 5 Inhibitors; Phosphodiesterase Inhibitors; Piperazines; Purines; RNA, Messenger; Sex Characteristics; Sildenafil Citrate; Skin; Sulfones; Tadalafil; Tail; Triazines; Vardenafil Dihydrochloride | 2009 |